Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin

Watson P. Folk, Alpana Kumari, Tetsushi Iwasaki, Slovénie Pyndiah, Joanna C. Johnson, Erica K. Cassimere, Amy L. Abdulovic-Cui, Daitoku Sakamuro

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds